News of the Canadian National Breast Screening Study and its findings have been making waves in the media recently.
But what do the findings really mean?
Dr. László Tabár, M.D., F.A.C.R. (Hon), is familiar with the study. Dr. Tabár was invited personally by the study's leader, Dr. Anthony Miller, to look at the study's process, image quality and imaging techniques.
What should women take from this trial? According to Dr. Tabár, women should take home one message: go for a mammogram, starting at age 40, and disregard this trial's findings.
To learn more about the trial, Dr. Tabár's involvement, and the study's findings, watch the video below.
Comments from Colleagues
Additional feedback from colleagues of Dr. Tabár can be read below.
- Michael N. Linver, MD, FACR - New York Times (Feb 2014)
- László Tabár, M.D., F.A.C.R.(Hon) Sweden - New York Times (Feb 2014)
- Dr. Paula Gordon - Vancouver Sun (February 2014)
- László Tabár andTony Hsiui-Hsi Chen - AuntMinnie.com (Feb 2014)
- Drs. Linver and Tabár - Dr. Anthony Miller letter, University of Toronto (February 2014)
- Robert A. Schmidt, MD - New York Times (Feb 2014)
- Martin J. Yaffe, PhD - Revised CNBSS Report (Feb 2014)
- Various Responses to the Canadian Research Published in the BMJ
- Norman F. Boyd, MD - Canadian Medical Association Journal (1997)
- Robert E. Tarone, Ph.D. - Report on Advanced Cancer Patients in CNBSS Study (Sept. 1994)
- Norman F. Boyd, MD, Roberta A. Jong, MD, et al - "A Critical Appraisal of the Canadian National Breast Cancer Screening Study, Radiology (December 1993)